Richard A. Larson to Hydrazines
This is a "connection" page, showing publications Richard A. Larson has written about Hydrazines.
Connection Strength
0.045
-
Phase I trial of maintenance selinexor after allogeneic hematopoietic stem cell transplantation for patients with acute myeloid leukemia and myelodysplastic syndrome. Bone Marrow Transplant. 2020 11; 55(11):2204-2206.
Score: 0.045